Anthony DeVico
21Patents
7h-index
15Co-inventors
66Inventor score
Filing activity: May 8, 1995 → Feb 22, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7311920B1 | Virus coat protein/receptor chimeras and methods of use | Physics | 29 | Expired |
| US5518723A | HIV immunogenic complexes | Emerging Cross-Sectional Technologies | 22 | Expired |
| US5843454A | HIV immunogenic complexes | Emerging Cross-Sectional Technologies | 19 | Expired |
| US6030772A | Neutralizing antibodies against HIV infection | Emerging Cross-Sectional Technologies | 15 | Expired |
| US6214540A | Chemokines that inhibit immunodeficiency virus infection and methods based thereon | Chemistry; Metallurgy | 13 | Expired |
| US6399078B1 | Chemokine—glycosaminoglycan complexes and their use in treating or preventing receptor mediated diseases | Emerging Cross-Sectional Technologies | 13 | Expired |
| US8183354B2 | Virus coat protein/receptor chimeras and methods of use | Physics | 9 | Active |
| US6569418B1 | Immuno-modulating effects of chemokines in DNA vaccination | Chemistry; Metallurgy | 6 | Expired |
| US6465172B1 | HIV immunogenic complexes comprising GP120 covalently bound to CD4 or concanavalin A | Emerging Cross-Sectional Technologies | 5 | Expired |
| US6919319B2 | Immuno-modulating effects of chemokines in DNA vaccination | Chemistry; Metallurgy | 2 | Expired |
| US6328973A | Method of raising neutralizing antibodies against HIV | Emerging Cross-Sectional Technologies | 2 | Expired |
| US6548631B1 | Macrophage derived chemokine (MDC) as an anti-viral agent for the treatment and prevention of lentivirus infection | Human Necessities | 1 | Expired |
| US7384641B2 | Immuno-modulating effects of chemokines in DNA vaccination | Chemistry; Metallurgy | 1 | Expired |
| US6908612B2 | Virus coat protein/receptor chimeras and methods of use | Physics | 1 | Expired |
| US9951106B2 | Recombinant fusion protein comprising HIV gp120 linked to an enhancing CD4 binding site mAb | Chemistry; Metallurgy | 1 | Active |
| US6503736B1 | Antibodies to crosslinkers and methods for using the same | Emerging Cross-Sectional Technologies | 0 | Expired |
| US11067583B2 | Methods of making active antibodies from biological fluids | Electricity | 0 | Active |
| US12331105B2 | Broadly neutralizing antibodies against HIV | Chemistry; Metallurgy | 0 | Active |
| US7708983B2 | Directional induction of immune response by co-administration of antigens with chemokines | Chemistry; Metallurgy | 0 | Active |
| US7399473B2 | Virus coat protein/receptor chimeras and method of use | Physics | 0 | Expired |
| US11760789B2 | Broadly neutralizing antibodies against HIV | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.